
| |
|
Sporadic inclusion body
myositis (sIBM) is an inflammatory muscle disease,
characterized by slowly progressive weakness and wasting
of the distal and proximal muscles, most apparent in the
muscles of the arms and legs. In sporadic inclusion body
myositis [MY-oh-sigh-tis] muscle, two processes, one
autoimmune and the other degenerative, appear to occur
in the muscle cells in parallel. The inflammation aspect
is characterized by the cloning of T cells that appear
to be driven by specific antigens to invade muscle
fibers. The degeneration aspect is characterized by the
appearance of holes in the muscle cell (vacuole)s,
deposits of amyloid-related proteins within the cells
and filamentous inclusions (hence the name inclusion
body myositis) of abnormal proteins. |
|
|
|
 |

|
Clinical Research on Mysotab |
| |
Mysotab is clinically proven to
treat Inclusion Body Myositis successfully. You may download a summary of our
clinical study in Adobe's PDF format. Click
here for details.
|
|
|
Mysotab
Guarantee |
| |
Mysotab is a completely
guaranteed treatment. You are at no risk for trying Mysotab. Click
here for details.
|
|
|